BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Contract Services

Vetter Introduces Next-Gen V-OVS® Closure System: Integrating Customer Insights for Enhanced Performance

New version integrates valuable real-world learnings and customer feedback The latest version of Vetter’s proprietary closure system, V-OVS®&n...

January 15, 2025 | News

Aragen Secures $100 Mn Investment from Quadria Capital, Valued at $1.4 Bn

Aragen, a globally renowned Contract Research, Development and Manufacturing Organization (CRDMO), announced that it has secured a $100 Mn investment...

January 13, 2025 | News

Biofidelity and CellCarta Forge Partnership to Advance Lung Cancer Genomic Testing in Clinical Trials

Biofidelity, a leader in innovative genomic solutions, and CellCarta, the global contract research organization (CRO) partner of choice for biopharmac...

January 10, 2025 | News

WuXi Biologics Partners with Candid Therapeutics in $925M Deal to Advance Trispecific T-Cell Engagers

WuXi Biologics ("WuXi Bio") (2269. HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced an agreemen...

January 07, 2025 | News

WuXi Biologics to Sell $500M Irish Vaccine Facility to Merck & Co. Amid U.S. Legislative Pressures

WuXi Biologics has announced plans to sell its vaccine manufacturing facility in Dundalk, Ireland, to Merck & Co. for approximately $500 million. This ...

January 06, 2025 | News

I Peace Achieves Milestone of Manufacturing 100 GMP-Grade iPS Cell Lines

Leading GMP cell CDMO I Peace, Inc., specializing in induced pluripotent stem cells (iPSCs) and iPSC-derived cell therapies, announced that the n...

December 31, 2024 | News

WuXi AppTec Divests Advanced Therapies Unit Amidst US BioSecure Act Scrutiny in Strategic Deal with Altaris, LLC

WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life scie...

December 27, 2024 | News

Lonza Opens State-of-the-Art R&D Facility in Slough, UK to Drive Biologics Innovation

Lonza, a global leader in biotechnology and pharmaceutical manufacturing, is proud to announce the opening of its new state-of-the-art research and develop...

December 19, 2024 | News

HiRO Partners with South Korea’s CHA Bundang Medical Center to Advance Global Clinical Trials

Harvest Integrated Research Organization (HiRO), a boutique global clinical research organization (CRO) providing cross-border clinical trial sol...

December 16, 2024 | News

SK pharmteco Unifies Global Brands to Establish CDMO Powerhouse

SK pharmteco, a global contract development, manufacturing, and analytical testing organization serving the pharmaceutical and cell & gene therapy indu...

December 12, 2024 | News

Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial

In an exclusive conversation with BioPharma APAC, Stefan Scheidl, VP and Global Head of Ophthalmology Medical Affairs at Roche, delves into the g...

December 02, 2024 | Interview

Samsung Biologics Secures USD 668 Million in Manufacturing Deals with Europe, Surpasses USD 4 Billion in 2024 Global Contract Value

The company will provide manufacturing services through 2031 in deals worth over USD 668 million Samsung Biologics' cumulative contract value for 2...

November 20, 2024 | News

Medidata and Bioforum Expand Partnership to Enhance AI-Driven Clinical Trials for Biotech Clients

-Medidata, a Dassault Systèmes brand and a leading provider of clinical trial solutions for the life sciences industry announced a new corporate agr...

November 18, 2024 | News

SEKISUI Diagnostics Completes £15.7 Million cGMP Expansion for Enhanced Microbial Drug Substance Manufacturing in the UK

SEKISUI Diagnostics' microbial CDMO business announces it has completed construction of its £15.7 million ($20.7 million) cGMP capacity expansion&nbs...

November 15, 2024 | News

Stay Connected